Holen Sie sich die Stockscreener-App
5.99
9.61%
0.525
Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten
Published on: 2025-08-21 06:55:08 - newsyoung.net
Bollinger Bands Expand on Verrica Pharmaceuticals Inc. — Volatility AheadMarket Weekly Review & Weekly Setup with High ROI Potential - thegnnews.com
Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Declines By 32.3% - Defense World
Verrica Pharmaceuticals Inc.’s volatility index tracking explainedInsider Buying & Expert-Curated Trade Recommendations - Newser
Can Verrica Pharmaceuticals Inc. hit a new high this monthTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
Real time scanner hits for Verrica Pharmaceuticals Inc. explainedQuarterly Portfolio Summary & Weekly Setup with High ROI Potential - Newser
Detecting price anomalies in Verrica Pharmaceuticals Inc. with AIJuly 2025 Highlights & Low Risk Investment Opportunities - Newser
Verrica Pharmaceuticals Streamlines Operations to Enhance YCANTH Access - MSN
Verrica Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Stock Recap & Weekly High Conviction Trade Ideas - Newser
Is Verrica Pharmaceuticals Inc. showing signs of accumulationQuarterly Trade Review & Free Accurate Trade Setup Notifications - Newser
What earnings revisions data tells us about Verrica Pharmaceuticals Inc.July 2025 Closing Moves & Weekly Setup with ROI Potential - Newser
Verrica Pharmaceuticals Posts Strong Q2 Growth, Advances Basal Cell Carcinoma Program - MSN
Can Verrica Pharmaceuticals Inc. recover in the next quarter2025 Market Sentiment & Daily Market Momentum Tracking - Newser
Leading vs lagging indicators on Verrica Pharmaceuticals Inc. performance2025 Short Interest & Target Return Focused Stock Picks - Newser
Real time social sentiment graph for Verrica Pharmaceuticals Inc.July 2025 Decliners & Low Risk High Reward Ideas - Newser
Verrica Pharmaceuticals Inc. Ranks High in Smart Money TrackerWeekly Trading Summary & Free Safe Capital Growth Stock Tips - beatles.ru
Can machine learning forecast Verrica Pharmaceuticals Inc. recoveryQuarterly Trade Review & Growth Focused Entry Reports - Newser
Analyzing drawdowns of Verrica Pharmaceuticals Inc. with statistical tools - Newser
Sentiment analysis tools applied to Verrica Pharmaceuticals Inc.Market Volume Summary & Real-Time Volume Triggers - Newser
What does recent volatility data suggest for Verrica Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Stock Reports - Newser
Verrica Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SayJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Is Verrica Pharmaceuticals Inc. trending in predictive chart modelsTake Profit & Verified Swing Trading Watchlist - Newser
Does Verrica Pharmaceuticals Inc. have declining or rising EPSQuarterly Market Review & Scalable Portfolio Growth Ideas - sundaytimes.kr
Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attention2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Market reaction to Verrica Pharmaceuticals Inc.’s recent newsGlobal Markets & Risk Adjusted Swing Trade Ideas - Newser
Sector ETF Data Correlates with Strength in Verrica Pharmaceuticals Inc.Trade Analysis Report & Growth Oriented Trading Recommendations - sundaytimes.kr
What makes Verrica Pharmaceuticals Inc. stock price move sharply2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Historical volatility pattern of Verrica Pharmaceuticals Inc. visualized2025 Major Catalysts & Long Hold Capital Preservation Plans - Newser
Verrica Pharmaceuticals shares rise 2.28% after-hours following Q2 2025 earnings call. - AInvest
Verrica Posts Profit in Fiscal Q2 - AOL.com
Verrica Pharmaceuticals stock price target raised to $20 by TD Cowen - Investing.com Canada
Verrica Pharmaceuticals Reaches Nasdaq Compliance, Q2 Revenue at $12.7M - AInvest
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q2 2025 Earnings Call Transcript - Insider Monkey
Verrica Pharmaceuticals: Promising Sales Growth Amid Financial Stability Concerns - TipRanks
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates - MSN
Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Verrica Pharmaceuticals Inc (VRCA) Q2 2025 Earnings Call Highlig - GuruFocus
Verrica Pharmaceuticals Sees Revenue Surge in Q2 2025 - TipRanks
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results - GlobeNewswire
Verrica Posts Profit in Fiscal Q2 - The Motley Fool
Verrica Pharmaceuticals' Q2 2025: Unpacking Contradictions in Sales Strategies, Seasonality, and Patient Access - AInvest
Verrica Pharmaceuticals (VRCA) Q2 2025 Earnings and Strategic Pipeline Catalysts: A Case for Re-Rating and Investor Re-Entry - AInvest
Earnings call transcript: Verrica Pharmaceuticals Q2 2025 beats EPS forecast By Investing.com - Investing.com Nigeria
Earnings call transcript: Verrica Pharmaceuticals Q2 2025 beats EPS forecast - Investing.com
Verrica Pharmaceuticals Regains Nasdaq Compliance - TipRanks
VERRICA PHARMACEUTICAL Earnings Results: $VRCA Reports Quarterly Earnings - Quiver Quantitative
Verrica Pharmaceuticals earnings beat by $0.11, revenue topped estimates - Investing.com Canada
1.38%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):